
Generating
Immunity For Life
Our Mission
Corner seeks to transform standard of care, ushering in a new era of rapid, patient-friendly and low-cost immunotherapies – even for the most difficult to treat diseases.
Corner is pioneering a new class of muti-purpose immunotherapies that protect the young and old. Our versatile dendritic cell hyperactivation (hDC) platform induces exceptional memory T cell responses that provide robust and durable immunity against a virtually unbounded range of cancers and infectious diseases.

Our Science
Bridging knowledge gaps that limit the success of current immunotherapies.
Why are we unique?
We generate exceptional memory T cells that provide life-long immunity
Our platform uses a new class of immunotherapy called hyperactivators which enhances the intelligence of dendritic cells (DCs) beyond what is possible with current therapies. As apex regulators of our immune system, DCs can generate a diverse repertoire of long-lived memory T cells. Our hyperactivators represent the only immunotherapy that enables DCs to stimulate T cell mediated immunity—for life.
We unleash the power of inflammasome activation within live DCs
Hyperactivators stimulate inflammasomes within living DCs to enable production of IL-1β, the key immunostimulant that drives memory T cell activity. Prior attempts to target DCs therapeutically have failed to provide durable immunity – they either cannot stimulate the IL-1β signal, or they use inflammasome stimuli that kill DCs via pyroptosis. By unleashing IL-1β signals from living DCs, we induce long lasting memory T cells that provide immunity for life.
We lead DCs to be in the right place, at the right time
Our proprietary hyperactivators are uniquely capable of stimulating DC migration to lymph nodes, where naïve and memory T cells are activated. While previous attempts to stimulate DC activities were poor inducers of migration, we ensure these apex immune regulators are in the right place, at the right time, to promote durable immunity.
We are antigen agnostic
Our muti-purpose platform can target a wide array of antigens ranging from known single antigens to a complex source of unidentified antigens. We are leading a new era of rapid and low-cost immunotherapies. We provide personalized immunotherapy that is available for all patients within days.